The fibrillogenic L178H variant of apolipoprotein A-I forms helical fibrils
A number of amyloidogenic variants of apoA-I have been discovered but most have not been analyzed. Previously, we showed that the G26R mutation of apoA-I leads to increased β-strand structure, increased N-terminal protease susceptibility, and increased fibril formation after several days of incubati...
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2012-03-01
|
Series: | Journal of Lipid Research |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0022227520413549 |
id |
doaj-34ec895221cc42f0a984351acafe00e3 |
---|---|
record_format |
Article |
spelling |
doaj-34ec895221cc42f0a984351acafe00e32021-04-28T06:04:37ZengElsevierJournal of Lipid Research0022-22752012-03-01533390398The fibrillogenic L178H variant of apolipoprotein A-I forms helical fibrilsJitka Petrlova0Trang Duong1Megan C. Cochran2Annika Axelsson3Matthias Mörgelin4Linda M. Roberts5Jens O. Lagerstedt6Department of Experimental Medical Sciences, Lund University, S-221 84 Lund, Sweden; andDepartment of Chemistry, California State University Sacramento, Sacramento, CA 95819Department of Chemistry, California State University Sacramento, Sacramento, CA 95819Department of Experimental Medical Sciences, Lund University, S-221 84 Lund, Sweden; andDepartment of Experimental Medical Sciences, and Department of Infection Medicine, Lund University, S-221 84 Lund, Sweden; andTo whom correspondence should be addressed. (J. O. L.) or (L. M. R.); Department of Chemistry, California State University Sacramento, Sacramento, CA 95819To whom correspondence should be addressed. (J. O. L.) or (L. M. R.); Department of Experimental Medical Sciences, Lund University, S-221 84 Lund, Sweden; andA number of amyloidogenic variants of apoA-I have been discovered but most have not been analyzed. Previously, we showed that the G26R mutation of apoA-I leads to increased β-strand structure, increased N-terminal protease susceptibility, and increased fibril formation after several days of incubation. In vivo, this and other variants mutated in the N-terminal domain (residues 26 to ∼90) lead to renal and hepatic accumulation. In contrast, several mutations identified within residues 170 to 178 lead to cardiac, laryngeal, and cutaneous protein deposition. Here, we describe the structural changes in the fibrillogenic variant L178H. Like G26R, the initial structure of the protein exhibits altered tertiary conformation relative to wild-type protein along with decreased stability and an altered lipid binding profile. However, in contrast to G26R, L178H undergoes an increase in helical structure upon incubation at 37°C with a half time (t1/2) of about 12 days. Upon prolonged incubation, the L178H mutant forms fibrils of a diameter of 10 nm that ranges in length from 30 to 120 nm. These results show that apoA-I, known for its dynamic properties, has the ability to form multiple fibrillar conformations, which may play a role in the tissue-specific deposition of the individual variants.http://www.sciencedirect.com/science/article/pii/S0022227520413549high density lipoproteinapoA-Ifibril formationamyloidprotein stability |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Jitka Petrlova Trang Duong Megan C. Cochran Annika Axelsson Matthias Mörgelin Linda M. Roberts Jens O. Lagerstedt |
spellingShingle |
Jitka Petrlova Trang Duong Megan C. Cochran Annika Axelsson Matthias Mörgelin Linda M. Roberts Jens O. Lagerstedt The fibrillogenic L178H variant of apolipoprotein A-I forms helical fibrils Journal of Lipid Research high density lipoprotein apoA-I fibril formation amyloid protein stability |
author_facet |
Jitka Petrlova Trang Duong Megan C. Cochran Annika Axelsson Matthias Mörgelin Linda M. Roberts Jens O. Lagerstedt |
author_sort |
Jitka Petrlova |
title |
The fibrillogenic L178H variant of apolipoprotein A-I forms helical fibrils |
title_short |
The fibrillogenic L178H variant of apolipoprotein A-I forms helical fibrils |
title_full |
The fibrillogenic L178H variant of apolipoprotein A-I forms helical fibrils |
title_fullStr |
The fibrillogenic L178H variant of apolipoprotein A-I forms helical fibrils |
title_full_unstemmed |
The fibrillogenic L178H variant of apolipoprotein A-I forms helical fibrils |
title_sort |
fibrillogenic l178h variant of apolipoprotein a-i forms helical fibrils |
publisher |
Elsevier |
series |
Journal of Lipid Research |
issn |
0022-2275 |
publishDate |
2012-03-01 |
description |
A number of amyloidogenic variants of apoA-I have been discovered but most have not been analyzed. Previously, we showed that the G26R mutation of apoA-I leads to increased β-strand structure, increased N-terminal protease susceptibility, and increased fibril formation after several days of incubation. In vivo, this and other variants mutated in the N-terminal domain (residues 26 to ∼90) lead to renal and hepatic accumulation. In contrast, several mutations identified within residues 170 to 178 lead to cardiac, laryngeal, and cutaneous protein deposition. Here, we describe the structural changes in the fibrillogenic variant L178H. Like G26R, the initial structure of the protein exhibits altered tertiary conformation relative to wild-type protein along with decreased stability and an altered lipid binding profile. However, in contrast to G26R, L178H undergoes an increase in helical structure upon incubation at 37°C with a half time (t1/2) of about 12 days. Upon prolonged incubation, the L178H mutant forms fibrils of a diameter of 10 nm that ranges in length from 30 to 120 nm. These results show that apoA-I, known for its dynamic properties, has the ability to form multiple fibrillar conformations, which may play a role in the tissue-specific deposition of the individual variants. |
topic |
high density lipoprotein apoA-I fibril formation amyloid protein stability |
url |
http://www.sciencedirect.com/science/article/pii/S0022227520413549 |
work_keys_str_mv |
AT jitkapetrlova thefibrillogenicl178hvariantofapolipoproteinaiformshelicalfibrils AT trangduong thefibrillogenicl178hvariantofapolipoproteinaiformshelicalfibrils AT meganccochran thefibrillogenicl178hvariantofapolipoproteinaiformshelicalfibrils AT annikaaxelsson thefibrillogenicl178hvariantofapolipoproteinaiformshelicalfibrils AT matthiasmorgelin thefibrillogenicl178hvariantofapolipoproteinaiformshelicalfibrils AT lindamroberts thefibrillogenicl178hvariantofapolipoproteinaiformshelicalfibrils AT jensolagerstedt thefibrillogenicl178hvariantofapolipoproteinaiformshelicalfibrils AT jitkapetrlova fibrillogenicl178hvariantofapolipoproteinaiformshelicalfibrils AT trangduong fibrillogenicl178hvariantofapolipoproteinaiformshelicalfibrils AT meganccochran fibrillogenicl178hvariantofapolipoproteinaiformshelicalfibrils AT annikaaxelsson fibrillogenicl178hvariantofapolipoproteinaiformshelicalfibrils AT matthiasmorgelin fibrillogenicl178hvariantofapolipoproteinaiformshelicalfibrils AT lindamroberts fibrillogenicl178hvariantofapolipoproteinaiformshelicalfibrils AT jensolagerstedt fibrillogenicl178hvariantofapolipoproteinaiformshelicalfibrils |
_version_ |
1721504254916558848 |